Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,012
datasets available to search
ShareScore release 0.9.0
Dataset results
2,012 results for “Kinase”
REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases
ClinicalTrials.gov study NCT07160231. IPD Sharing: NO. Countries: 1. Publications: 0.
A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT04605211. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
ClinicalTrials.gov study NCT07221500. IPD Sharing: NO. Countries: 4. Publications: 0.
Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder
ClinicalTrials.gov study NCT05373719. IPD Sharing: YES. Countries: 7. Publications: 0.
Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase Inhibitor in Liver Transplantation
ClinicalTrials.gov study NCT05448339. IPD Sharing: NO. Countries: 1. Publications: 0.
Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies.
ClinicalTrials.gov study NCT01636908. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor
ClinicalTrials.gov study NCT02734823. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer
ClinicalTrials.gov study NCT00074867. IPD Sharing: Not stated. Countries: 2. Publications: 0.
The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial
ClinicalTrials.gov study NCT04562428. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts W/Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT06229860. IPD Sharing: NO. Countries: 1. Publications: 0.
Gene Therapy for Pyruvate Kinase Deficiency (PKD)
ClinicalTrials.gov study NCT04105166. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis
ClinicalTrials.gov study NCT04878003. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
ClinicalTrials.gov study NCT05168163. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT02164942. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Role of Janus Kinase (JAK) and Voltage-gated Sodium Channels (Nav) on Pain and Itch
ClinicalTrials.gov study NCT07203274. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor
ClinicalTrials.gov study NCT02496663. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Janus Kinase Inhibition in Sarcoidosis
ClinicalTrials.gov study NCT05696795. IPD Sharing: NO. Countries: 1. Publications: 0.
Characteristics and Predictors of Liver Injury in Cyclin-dependent Kinase Inhibitors 4/6 (CDK4/6)-Treated Patients With Advanced Breast Cancer
ClinicalTrials.gov study NCT06367335. IPD Sharing: NO. Countries: 1. Publications: 0.
Pyruvate Kinase (PK) Deficiency Global Longitudinal Registry: Patient-Reported Outcomes (PRO)
ClinicalTrials.gov study NCT04964323. IPD Sharing: NO. Countries: 5. Publications: 0.
Orelabrutinib Therapy in Patients With r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase Inhibitors
ClinicalTrials.gov study NCT05495828. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.